Cite
Paradis JS, Acosta M, Saddawi-Konefka R, et al. Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for . Clin Cancer Res. 2021;27(16):4664doi: 10.1158/1078-0432.CCR-21-2433.
Paradis, J. S., Acosta, M., Saddawi-Konefka, R., Kishore, A., Lubrano, S., Gomes, F., Arang, N., Tiago, M., Coma, S., Wu, X., Ford, K., Day, C. P., Merlino, G., Mali, P., Pachter, J. A., Sato, T., Aplin, A. E., & Gutkind, J. S. (2021). Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for . Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4664. https://doi.org/10.1158/1078-0432.CCR-21-2433
Paradis, Justine S, et al. "Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4664. doi: https://doi.org/10.1158/1078-0432.CCR-21-2433
Paradis JS, Acosta M, Saddawi-Konefka R, Kishore A, Lubrano S, Gomes F, Arang N, Tiago M, Coma S, Wu X, Ford K, Day CP, Merlino G, Mali P, Pachter JA, Sato T, Aplin AE, Gutkind JS. Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for . Clin Cancer Res. 2021 Aug 15;27(16):4664. doi: 10.1158/1078-0432.CCR-21-2433. PMID: 34389658.
Copy
Download .nbib